NovaBay Pharmaceuticals, Inc. Announces Board and Committee Changes
April 03, 2020 at 09:33 pm
Share
On March 31, 2020, Ms. Gail Maderis informed NovaBay Pharmaceuticals, Inc. of her resignation as a member of the Company’s Board of Directors (the “Board”), with such resignation to be effective immediately. The Board appointed an existing independent Board member, Ms. Swan Sit, to fulfill the vacancies left on the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee as a result of Ms. Maderis’ resignation. Further, the Board appointed Dr. Yenyou (Jeff) Zheng to serve as both the Chairman of the Audit Committee and as the Audit Committee Financial Expert, also resulting from Ms. Maderis’ resignation from those roles. Ms. Maderis did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Board accepted the resignation of Ms. Maderis and reduced the size of the Board from seven to six members effective with her resignation.
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.